Obesity, inflammation, and liver cancer

Slides:



Advertisements
Similar presentations
EASL Clinical Practice Guidelines: Vascular diseases of the liver Journal of Hepatology Volume 64, Issue 1, Pages (January 2016) DOI: /j.jhep
Advertisements

Omega 3 – Omega 6: What is right for the liver? Ashraf Mohammad El-Badry, Rolf Graf, Pierre-Alain Clavien Journal of Hepatology Volume 47, Issue 5, Pages.
Volume 63, Issue 1, Pages (July 2015)
Volume 46, Issue 3, Pages (March 2007)
Nutritional therapy for nonalcoholic fatty liver disease
Inflammasomes in liver diseases
Oxidants and antioxidants in alcohol-induced liver disease
Lifestyle interventions for the treatment of non-alcoholic fatty liver disease in adults: A systematic review  Christian Thoma, Christopher P. Day, Michael.
Tiny RNA with great effects: miR-155 in alcoholic liver disease
Immunotherapy of hepatocellular carcinoma
Pathological roles of purinergic signaling in the liver
The yin and yang of evasion and immune activation in HCC
The inflammasome in liver disease
Reactive oxygen species in the normal and acutely injured liver
Cédric Coulouarn, Bruno Clément  Journal of Hepatology 
Matthew T. Kitson, Stuart K. Roberts  Journal of Hepatology 
Gianluca Tell, Carlo Vascotto, Claudio Tiribelli  Journal of Hepatology 
Oxidants and antioxidants in alcohol-induced liver disease
Volume 57, Issue 1, Pages 6-8 (July 2012)
Metabolic stress-induced joint inflammation and osteoarthritis
Jean-Charles Nault, Jessica Zucman-Rossi  Journal of Hepatology 
Fatty Acid-Induced T Cell Loss Greases Liver Carcinogenesis
Data Triumph at C Cancer Cell
Roles for Chemokines in Liver Disease
Living donor liver transplantation: is the hype over?
Nicolas Moniaux, Jamila Faivre  Journal of Hepatology 
Volume 55, Issue 4, Pages (October 2011)
Mesenchymal stromal cell therapy for liver diseases
Ludger Scheja, Joerg Heeren  Journal of Hepatology 
Targeting the gut-liver axis in liver disease
Inflammation and portal hypertension – The undiscovered country
Regulatory T-cell directed therapies in liver diseases
Hepatitis C core protein – The “core” of immune deception?
Signalling pathways in alcohol-induced liver inflammation
I. Carmona, P. Cordero, J. Ampuero, A. Rojas, M. Romero-Gómez 
Targeting gut flora to prevent progression of hepatocellular carcinoma
Amalia Gastaldelli, Giulio Marchesini  Journal of Hepatology 
Mechanisms of iron hepatotoxicity
Statin use and the risk of hepatocellular carcinoma in patients at high risk: A nationwide nested case-control study  Gyuri Kim, Suk-Yong Jang, Chung.
The yin and yang of evasion and immune activation in HCC
Volume 61, Issue 1, Pages S69-S78 (November 2014)
IKKɛ: A Bridge between Obesity and Inflammation
EASL Clinical Practice Guidelines: Wilson’s disease
Veronika Lukacs-Kornek, Detlef Schuppan  Journal of Hepatology 
Bin Gao, Hua Wang, Fouad Lafdil, Dechun Feng  Journal of Hepatology 
Cannabinoid signaling and liver therapeutics
Volume 63, Issue 2, Pages (August 2015)
Karel J. van Erpecum, Frank G. Schaap  Journal of Hepatology 
Cédric Coulouarn, Bruno Clément  Journal of Hepatology 
Arjan Boltjes, Dowty Movita, André Boonstra, Andrea M. Woltman 
NASH animal models: Are we there yet?
The potential of induced pluripotent stem cell derived hepatocytes
Global burden of alcoholic liver diseases
Therapeutic strategies in inflammasome mediated diseases of the liver
HCV targeting of patients with cirrhosis
Volume 44, Issue 5, Pages (May 2006)
Role of desmoplasia in cholangiocarcinoma and hepatocellular carcinoma
Volume 63, Issue 1, Pages (July 2015)
Macrophage heterogeneity in liver injury and fibrosis
Silvia Affò, Ramón Bataller  Journal of Hepatology 
Molecular mechanism of PPARα action and its impact on lipid metabolism, inflammation and fibrosis in non-alcoholic fatty liver disease  Michal Pawlak,
Ana Lleo, M. Eric Gershwin, Alberto Mantovani, Pietro Invernizzi 
Pathogenesis of cholestatic hepatitis C
Inflammatory pathways in alcoholic steatohepatitis
Foxa1 and Foxa2 regulate bile duct development in mice
Volume 61, Issue 2, Pages (August 2014)
Nathalie Ganne-Carrié, Pierre Nahon  Journal of Hepatology 
Shih-Yen Weng, Detlef Schuppan  Journal of Hepatology 
Immunity, Inflammation, and Cancer
IL-1β Activation as a Response to Metabolic Disturbances
Presentation transcript:

Obesity, inflammation, and liver cancer Beicheng Sun, Michael Karin  Journal of Hepatology  Volume 56, Issue 3, Pages 704-713 (March 2012) DOI: 10.1016/j.jhep.2011.09.020 Copyright © 2011 European Association for the Study of the Liver Terms and Conditions

Fig. 1 Three putative mechanisms for obesity-induced and obesity-promoted hepatocarcinogenesis. ROS, reactive oxygen species; RNS, reactive nitrogen species. Journal of Hepatology 2012 56, 704-713DOI: (10.1016/j.jhep.2011.09.020) Copyright © 2011 European Association for the Study of the Liver Terms and Conditions

Fig. 2 Adipokines, cytokines, and hepatocarcinogenesis. Excessive free fatty acids (FFAs) can activate various immune cells and cause hepatocytes cell death. Moreover, cell debris, pro-inflammatory cytokines and adipokines can further enhance TNF and IL-6 secretion from Kupffer cells, leading to activation of downstream signaling molecules, such as STAT3 in hepatocytes which contribute to hepatocarcinogenesis. Journal of Hepatology 2012 56, 704-713DOI: (10.1016/j.jhep.2011.09.020) Copyright © 2011 European Association for the Study of the Liver Terms and Conditions

Journal of Hepatology 2012 56, 704-713DOI: (10. 1016/j. jhep. 2011. 09 Copyright © 2011 European Association for the Study of the Liver Terms and Conditions

Journal of Hepatology 2012 56, 704-713DOI: (10. 1016/j. jhep. 2011. 09 Copyright © 2011 European Association for the Study of the Liver Terms and Conditions